We provide you with 20 years of free, institutional-grade data for ASMB stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ASMB. Explore the full financial landscape of ASMB stock.
| Reported Date | CIK | Ticker | Type |
|---|
Assembly Biosciences, Inc(NASDAQ:ASMB) 
Assembly Biosciences, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops oral therapeutic candidates for the treatment of hepatitis B virus (HBV) infection. Its product candidates include Vebicorvir to treat patients with chronic HBV infection; ABI-H21...
Website: http://www.assemblybio.com
Founded: 2005
Full Time Employees: 140
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about ASMB stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.